Molecular markers may improve risk assessment in oral potentially malignant disorders
Molecular tools may improve risk assessment for oral lesions
This narrative review examines the limitations of conventional histopathological grading for oral potentially malignant disorders (OPMDs) an…
A review suggests molecular methods could better assess risk for oral potentially malignant disorders where standard grading is unreliable.
Meta-analysis identifies transcriptomic and immune shifts in oral potentially malignant disorders
Your Mouth's Immune Signals Predict Oral Cancer Risk Earlier
This meta-analysis of five datasets examines transcriptomic patterns and signaling processes across stages of oral potentially malignant dis…
• Immune cell patterns flag dangerous mouth lesions before cancer develops • Helps people with persistent white or red mouth sores • Still n…
Meta-analysis of VELscope diagnostic accuracy for oral potentially malignant disorders
Meta-analysis reviews VELscope device for detecting oral potentially malignant disorders
This meta-analysis of 24 studies evaluated VELscope for detecting oral potentially malignant disorders.
The VELscope screening tool catches most oral cancer cases but often flags healthy mouths as risky, causing unnecessary worry and extra test…
Research across Cancer
Related studies from across the Cancer family.
Meta-analysis Evaluating Occupational Hexavalent Chromium Exposure and Specific Malignancy Risks
Occupational Chromium Exposure Linked to Bladder Cancer Mortality
A meta-analysis of 29 publications examined how occupational hexavalent chromium exposure impacts various cancer types in human populations.
A review of 29 publications found that while most cancers showed no link, bladder cancer mortality was associated with hexavalent chromium e…
Mirtazapine and olanzapine reduce anxiety and depression scores in oral cavity cancer patients
Two Common Pills Ease Cancer Anxiety and Depression
This randomized controlled trial included 144 patients with oral cavity cancer.
Two well-known antidepressants significantly eased anxiety and depression in oral cancer patients, with mirtazapine showing a slight edge.
Oral and pharyngeal cancer incidence increased in US population from 2007 to 2016
U.S. study finds rising rates of oral and throat cancers over a decade
An observational study of the US population from 2007 to 2016 found increasing incidence of combined oral cavity and pharyngeal cancers.
U.S. cancer rates for the mouth and throat rose between 2007 and 2016, possibly linked to more cases caused by HPV.